What is the current stock price of Channel Therapeutics Corporation (CHRO)?

As of the latest market data, Channel Therapeutics Corporation (CHRO) is trading at $1.35. The stock has seen a gain of 7.14% today.

Does Channel Therapeutics Corporation (CHRO) pay a dividend?

Based on current data, Channel Therapeutics Corporation does not have a confirmed active dividend policy.

What is the market cap of Channel Therapeutics Corporation?

The current market capitalization of Channel Therapeutics Corporation (CHRO) is approximately unavailable.

CHRO

Channel Therapeutics Corporation·Healthcare

1.35

7.143%(+0.09)

Market Closed

1.38

2.222%(+0.03)

After Hours

Last Updated: — ET

52W L: $1.2352W H: $54.29

Company Profile

Channel Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2024-02-16

Beta

3.29

Websitechanneltherapeutics.com↗